Revlimid Side Effects
>>>Help Community - Post Your Revlimid Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Revlimid Side Effects
Revlimid Safety Reports reported to FDA
Total Revlimid reports: 2621.Revlimid FDA safety alerts: No.
Reported deaths: 1518 Reported hospitalizations: 1034.
Take Revlimid Side Effects Survey or Share Your Revlimid Story.
Reported Revlimid Side Effects: death, disease progression, multiple myeloma, malignant neoplasm progression, fatigue, myelodysplastic syndrome, platelet count decreased, asthenia, pancytopenia, thrombocytopenia, white blood cell count decreased.
Revlimid Usage.
If you have questions about Revlimid, you can post them to our Doctors or Ask Patient Community about Revlimid.
Showing 1-50 of 2621 Next >
Revlimid Side Effects Report #5207249-9Health Professional from UNITED STATES reported REVLIMID problem on Jan 04, 2007. Female patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: unknown. Patient died on 11/17/2006.
Revlimid Side Effects Report #5208318-X
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 10, 2007. Male patient, 59 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: pyrexia. REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with PROCRIT, DEXAMETHASONE, CEPHALEXIN, WARFARIN, MORPHINE SULPHATE, OMEPRAZOLE, GABAPENTIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5208326-9
Pharmacist from UNITED STATES reported REVLIMID problem on Jan 10, 2007. Male patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity. REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with ACETAMINOPHEN AND OXYCODONE, DEXAMETHASONE, AREDIA, METOPROLOL SUCCINATE, TERAZOSIN, FAMOTIDINE, COLCHICINE, ACETAZOLAMIDE. Patient recovered.
Revlimid Side Effects Report #5208773-5
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 11, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neutropenia, thrombocytopenia. REVLIMID dosage: 25 MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, PROCRIT, ACETAMINOPHEN AND OXYCODONE, ATENOLOL, ISORDIL, GABAPENTIN, FEMARA, OMEPRAZOLE. Patient recovered.
Revlimid Side Effects Report #5211293-5
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Jan 08, 2007. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/13/2006.
Revlimid Side Effects Report #5211294-7
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 08, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: pneumonia fungal. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/04/2006.
Revlimid Side Effects Report #5211297-2
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: no adverse effect. REVLIMID dosage: 15 MG, DAILY, ORAL. Patient died on 08/06/2006.
Revlimid Side Effects Report #5211300-X
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 04, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5211303-5
Health Professional from UNITED STATES reported REVLIMID problem on Jan 03, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, platelet count increased, splenomegaly, white blood cell count increased. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5211305-9
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 20 MG, DAILY, ORAL. Patient died on 11/24/2006.
Revlimid Side Effects Report #5211308-4
Physician from UNITED STATES reported REVLIMID problem on Jan 05, 2007. Female patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/28/2006.
Revlimid Side Effects Report #5211310-2
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 79 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, renal failure acute. REVLIMID dosage: 10 MG, DAILY X 21 DAYS, ORAL; SEE IMAGE. Patient died on 12/25/2006.
Revlimid Side Effects Report #5211343-6
Physician from UNITED STATES reported REVLIMID problem on Jan 08, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, diabetes mellitus, failure to thrive, haematoma, malignant neoplasm progression, multiple myeloma, subdural haematoma. REVLIMID dosage: 25 MG, DAILY, ORAL. Patient died on 11/26/2006.
Revlimid Side Effects Report #5211368-0
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 08, 2007. Female patient, 65 years of age, was diagnosed with amyloidosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amyloidosis, disease progression, dyspnoea, lung disorder. REVLIMID dosage: unknown. Patient died on 12/04/2006.
Revlimid Side Effects Report #5211465-X
Physician from UNITED STATES reported REVLIMID problem on Jan 08, 2007. Male patient, 65 years of age, was diagnosed with lymphoma, myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, coronary artery disease, ejection fraction decreased, pulmonary hypertension, viral infection. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with LISINOPRIL, COREG, ALDACTONE, LASIX. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5211468-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 08, 2007. Female patient, 77 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/24/2006.
Revlimid Side Effects Report #5211471-5
Health Professional from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 15 MG, DAILY X 21 DAYS, ORAL. Patient died on 12/28/2006.
Revlimid Side Effects Report #5211491-0
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 08, 2007. Female patient, 88 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: confusional state, disorientation, hallucination, malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECADRON. Patient died on 01/05/2007.
Revlimid Side Effects Report #5211492-2
Physician from UNITED STATES reported REVLIMID problem on Jan 05, 2007. Female patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood human chorionic gonadotropin increased, pleural effusion, pregnancy test urine positive, pulmonary embolism. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECADRON, PROCRIT, LORTAB, HYZAAR, CALCIUM, DOXEPIN, XANAX, SKELAXIN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5211497-1
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 04, 2007. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, infection, malignant neoplasm progression, multiple myeloma, sepsis. REVLIMID dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with COREG, ACCUPRIL, BUMEX, NAPROSYN, NASONEX, DARVOCET, DURAGESIC, DECADRON. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5211500-9
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Female patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/30/2006.
Revlimid Side Effects Report #5212781-8
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 18, 2007. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. REVLIMID dosage: 10MG DAILY 21D/28D PO. During the same period patient was treated with LORAZEPAM, TERAZOSIN, MAXITROL, PROCRIT, COLCHICINE, ALLOPURINOL, OMEPRAZOLE, VICODIN. Patient recovered.
Revlimid Side Effects Report #5213244-6
Physician from UNITED STATES reported REVLIMID problem on Jan 05, 2007. Male patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5213247-1
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 04, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anorectal infection, catheter related infection, enterococcal sepsis, fatigue, groin infection, subacute endocarditis, weight decreased. REVLIMID dosage: 25 MG, QD X 21 DAYS, ORAL; SEE IMAGE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213248-3
Physician from UNITED STATES reported REVLIMID problem on Jan 04, 2007. Male patient, 67 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood potassium decreased, catheter related infection, convulsion, urinary tract infection. REVLIMID dosage: 10 MG, X 21 DAYS EVERY 28 DAYS,. During the same period patient was treated with ZOMETA, AVANDIA, NOVOLOG. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213901-1
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/26/2006.
Revlimid Side Effects Report #5213908-4
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Male patient was diagnosed with myelodysplastic syndrome, multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/04/2006.
Revlimid Side Effects Report #5213909-6
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 09, 2007. Female patient, 43 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: condition aggravated, multiple myeloma, pneumonia, respiratory failure. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 11/27/2006.
Revlimid Side Effects Report #5213910-2
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Female patient, 79 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased, blood potassium decreased, convulsion. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213911-4
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 10, 2007. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/18/2006.
Revlimid Side Effects Report #5213912-6
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: infection parasitic, pneumocystis jiroveci pneumonia. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/02/2006.
Revlimid Side Effects Report #5213913-8
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 09, 2007. Female patient, 67 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 15 MG, FOR 21 DAYS, ORAL. Patient died on 11/20/2006.
Revlimid Side Effects Report #5213914-X
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disease progression, gastritis erosive, gastrointestinal ulcer haemorrhage. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213916-3
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 10, 2007. Female patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: unknown. Patient died.
Revlimid Side Effects Report #5213917-5
Physician from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Female patient, 80 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, cardiac disorder, hyperplasia, leukopenia, renal failure, thrombocytopenia. REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213918-7
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 69 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5213919-9
Physician from UNITED STATES reported REVLIMID problem on Jan 08, 2007. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac failure congestive, coronary artery disease, epistaxis, fatigue, renal failure acute. REVLIMID dosage: unknown. During the same period patient was treated with COUMADIN, ASPIRIN, PROCRIT, LASIX. Patient was hospitalized. Patient died on 10/07/2006.
Revlimid Side Effects Report #5213920-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 74 years of age, was diagnosed with complex regional pain syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haematemesis, haemorrhage, rash. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COUMADIN, DILAUDID. Patient recovered.
Revlimid Side Effects Report #5213921-7
Pharmacist from UNITED STATES reported REVLIMID problem on Jan 10, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2006.
Revlimid Side Effects Report #5213922-9
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 10, 2007. Female patient, 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/22/2006.
Revlimid Side Effects Report #5213923-0
Health Professional from UNITED STATES reported REVLIMID problem on Jan 08, 2007. Female patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: dry skin, hair growth abnormal, mitral valve disease, oedema peripheral, rash, urinary incontinence. REVLIMID dosage: 25 MG, Q28 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5213927-8
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 81 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/16/2006.
Revlimid Side Effects Report #5213928-X
Pharmacist from UNITED STATES reported REVLIMID problem on Jan 08, 2007. Female patient, 51 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, viral infection. REVLIMID dosage: 5 MG, QD X14 DAYS, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213929-1
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 04, 2007. Female patient, 50 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma, bipolar disorder and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: encephalopathy. REVLIMID dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, TYLENOL, ACYCLOVIR, CEFEMINE, FOLIC ACID, HALDOL, SYNTHROID, ATIVAN. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5213930-8
Health Professional from UNITED STATES reported REVLIMID problem on Jan 09, 2007. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone pain, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma, pneumonia, pulmonary oedema, sepsis, thrombosis. REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient died on 01/02/2007.
Revlimid Side Effects Report #5213931-X
REVLIMID problem was reported by a Health Professional from UNITED STATES on Jan 10, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 5 MG , QD X 21 DAYS, ORAL. Patient died on 01/06/2007.
Revlimid Side Effects Report #5214187-4
Physician from CANADA reported REVLIMID problem on Jan 05, 2007. Male patient, 63 years of age, weighting 157.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, beta haemolytic streptococcal infection, blood calcium decreased, blood culture positive, blood uric acid decreased, candidiasis, cholestasis, coagulopathy, dialysis. REVLIMID dosage: 10 MG, DAILY, ORAL. During the same period patient was treated with NILSTAT, FLAGYL, TYLENOL II, ALLOPURINOL, NAPROSYN, IMODIUM. Patient was hospitalized. Patient died on 11/16/2006.
Revlimid Side Effects Report #5214870-0
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 22, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arthralgia, insomnia, malaise. REVLIMID dosage: 10MG DAILY FOR 21 DAYS PO. During the same period patient was treated with LACTULOSE, WARFARIN, TRAZODONE, RENAGEL. Patient recovered.
Revlimid Side Effects Report #5214879-7
Pharmacist from UNITED STATES reported REVLIMID problem on Jan 22, 2007. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cellulitis, platelet count decreased. REVLIMID dosage: 10MG FOR 21 DAYS PO. During the same period patient was treated with ATIVAN, TERAZOSIN, PROCRIT, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5215457-6
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Jan 19, 2007. Male patient, 40 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dehydration, hypercalcaemia, nausea, renal failure, vomiting. REVLIMID dosage: 25MG QD FOR 21 DAYS PO. Patient was hospitalized. Patient recovered.
Showing 1-50 of 2621 Next >
Drug Information: Lenalidomide
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a608001.html
(len a lid' oh mide)IMPORTANT WARNING:
| Risk of birth defects caused by lenalidomide:For all patients:Lenalidomide must not be taken by patients who are pregnant or who may become pregnant. There is a high risk that lenalidomide will cause loss of the pregnancy or will cause the baby to be born with birth defects (problems that are present at birth).A program called RevAssist® has been set up to make sure that pregnant women do not take lenalidomide and that women do not become pregnant while taking lenalidomide. All patients, including women who cannot become pregnant and men, can get lenalidomide only if they are registered with RevAssist®, have a prescription from a doctor who is registered with RevAssist® and fill the prescription at a pharmacy that is registered with RevAssist®.You will receive information about the risks of taking lenalidomide and must sign an informed consent sheet stating that you understand this information before you can receive the medication. If you are less than 18 years of age, a parent or guardian must sign the consent sheet and agree to make sure you meet these requirements. You will need to see your doctor during your treatment to talk about your condition and the side effects you are experiencing or to have pregnancy tests as recommended by the program.Tell your doctor if you do not understand everything you were told about lenalidomide and the RevAssist® program and how to use the birth control methods discussed with your doctor, or if you do not think you will be able to keep appointments.Do not donate blood while you are taking lenalidomide and for 4 weeks after your treatment.Do not share lenalidomide with anyone else, even someone who has the same symptoms that you have.Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with lenalidomide and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/cder), the manufacturer's website, or the RevAssist® program website (http://www.revlimid.com/hcp/hcp-revassist.aspx) to obtain the Medication Guide.Talk to your doctor about the risks of taking lenalidomide.For female patients:If you can become pregnant, you will need to meet certain requirements during your treatment with lenalidomide. You need to meet these requirements even if you have had a tubal ligation ('tubes tied'; surgery to prevent pregnancy). You may be excused from meeting these requirements only if you have not menstruated for 24 months in a row and your doctor says you have passed menopause (change of life) or you have had surgery to remove your uterus and/or both ovaries. If none of these are true for you, then you must meet the requirements below.You must use two acceptable forms of birth control for 4 weeks before you begin to take lenalidomide, during your treatment, including at times when your doctor tells you to temporarily stop taking lenalidomide, and for 4 weeks after your treatment. Your doctor will tell you which form of birth control are acceptable, and will give you written information about birth control. You must use these two forms of birth control at all times unless you can promise that you will not have any sexual contact with a male for 4 weeks before your treatment, during your treatment, during any interruptions in your treatment, and for 4 weeks after your treatment.If you choose to take lenalidomide, it is your responsibility to avoid pregnancy for 4 weeks before, during, and for 4 weeks after your treatment. You must understand that any form of birth control can fail. Therefore, it is very important to decrease the risk of accidental pregnancy by using two forms of birth control. Tell your doctor if you do not understand everything you were told about birth control or you do not think that you will be able to use two forms of birth control at all times.You must have two negative pregnancy tests before you can begin to take lenalidomide. You will also need to be tested for pregnancy in a laboratory at certain times during your treatment. Your doctor will tell you when and where to have these tests.Stop taking lenalidomide and call your doctor right away if you think you are pregnant, you miss a menstrual period, or you have sex without using two forms of birth control. If you become pregnant during your treatment or within 30 days after your treatment, your doctor will contact the RevAssist® program, the manufacturer of lenalidomide, and the Food and Drug Administration. (FDA). You will also talk with a doctor who specializes in problems during pregnancy who can help you make choices that are best for you and your baby. Information about your health and your baby's health will be used to help doctors learn more about the effects of lenalidomide on unborn babies.For male patients:It is not know if lenalidomide is present in your semen when you take prescribed doses of this medication. You must use a latex condom, even if you have had a vasectomy (surgery that prevents a man from causing a pregnancy), every time you have sexual contact with a female who is pregnant or able to become pregnant while you are taking lenalidomide and for 4 weeks after your treatment. Tell your doctor if you have sexual contact with a female without using a condom or if your partner thinks she may be pregnant during your treatment with lenalidomide.Do not donate sperm while you are taking lenalidomide and for 4 weeks after your treatment.Other risks of taking lenalidomide:Lenalidomide may cause a decrease in the number of certain types of blood cells in your body. Your doctor will order laboratory tests regularly during your treatment to see how much the number of blood cells has decreased. Your doctor may decrease your dose, interrupt your treatment, or treat you with other medications or treatments if the decrease in your blood cells is severe. If you experience any of the following symptoms, tell your doctor immediately: sore throat, fever, chills, and other signs of infection; easy bruising or bleeding; bleeding gums; or nosebleeds.If you are taking lenalidomide to treat multiple myeloma, there is a risk that you will develop a blood clot in your leg that may move through the bloodstream to your lungs. Your doctor may prescribe other medication to be taken along with lenalidomide to decrease this risk. If you experience any of the following symptoms, tell your doctor immediately: shortness of breath, chest pain, cough, or redness or swelling in an arm or leg. |
Why is this medication prescribed?
Lenalidomide is used to treat a certain type of myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). Lenalidomide is also used along with dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other medication. Lenalidomide is in a class of medications called immunomodulatory agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells in the bone marrow.
How should this medicine be used?
Lenalidomide comes as a capsule to take by mouth. When lenalidomide is used to treat myelodysplastic syndrome, it is usually taken with water once daily. When lenalidomide is used to treat multiple myeloma, it is usually taken with water once daily for 21 days and then is not taken for 7 days. This 28-day pattern may be repeated as recommended by your doctor. Take lenalidomide at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lenalidomide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the capsules whole; do not break, chew, or open them.
Your doctor may need to interrupt your treatment or reduce your dose if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with lenalidomide.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking lenalidomide,
- tell your doctor and pharmacist if you are allergic to lenalidomide, any other medications, or any of the ingredients in lenalidomide capsules. Ask your pharmacist or check the Medication Guide for a list of the ingredients.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention digoxin. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had kidney disease.
- do not breastfeed while you are taking lenalidomide.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. If you do not remember the missed dose until the next day, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Lenalidomide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- diarrhea
- constipation
- stomach pain
- nausea
- vomiting
- loss of appetite
- weight loss
- tiredness
- weakness
- dizziness
- headache
- change in ability to taste
- decreased sense of touch
- burning, tingling, or numbness in the hands or feet
- blurred vision
- difficulty falling asleep or staying asleep
- depression
- swelling of the arms, hands, feet, ankles, or lower legs
- joint, muscle, or back pain
- itching
- painful urination
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:
- pale skin
- shortness of breath
- fast or pounding heartbeat
- rash
- muscle cramps
Lenalidomide may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Keep all appointments with your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
Brand name(s):
|